Why the study?
How do pulmonary MR angiography and perfusion compare to multidetector CT angiography for the differential diagnosis of pulmonary hypertension?
How do pulmonary MR angiography and perfusion compare to multidetector CT angiography for the differential diagnosis of pulmonary hypertension?
Answers are grounded in this paper and cite their sources.
MRA and MRPP are promising radiation-free alternatives to MDCTA for evaluating pulmonary hypertension, though MDCTA remains the gold standard for CTEPH.
Pulmonary hypertension (PH) is a progressive disease that leads to substantial morbidity and eventual death. Pulmonary multidetector CT angiography (MDCTA), pulmonary MR angiography (MRA) and MR-derived pulmonary perfusion (MRPP) imaging are non-invasive imaging techniques for the differential diagnosis of PH. MDCTA is considered the gold standard for the diagnosis of pulmonary embolism, one of the most common causes of PH. MRA and MRPP are promising techniques that do not require the use of ionising radiation or iodinated contrast material, and can be useful for patients for whom such material cannot be used. This review compares the imaging aspects of pulmonary MRA and 64-row MDCTA in patients with chronic thromboembolic or idiopathic PH.
No takes yet. Share an insight, caveat, or question.
Junqueira et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: